ARTICLE | Clinical News
Onco TCS: Began Phase II trials
November 19, 2001 8:00 AM UTC
Inex Pharmaceuticals Corp. (TSE:IEX), Vancouver, B.C. Product: Onco TCS Business: Cancer Therapeutic category: Cytotoxic, Cell proliferation Target: Spindle microtubules Description: Transmembrane Ca...